Best of ASCO - 2014 Annual Meeting

 

Welcome

Genetic Testing

Cancer Prevention, Hereditary Genetics, and Epidemiology

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients.

Nadine M. Tung

e13624

An observational descriptive study of a newly implemented service of genetic counselling in Pasto (Colombia) between 2015 and 2016 in a low-middle income country.

Jorge Mauricio Melo

e13626

Clinical and molecular characteristics of NF1 mutations identified on hereditary cancer multi-gene panels.

Anton Mikhailovich Safonov

e13612

Detection of inherited mutations in Brazilian breast cancer patients using multi-gene panel testing.

Rodrigo Santa Cruz Guindalini

e13610

Disclosure of secondary germline findings from clinical tumor-normal paired somatic mutation profiling.

Molly S. Daniels

1510

Examining patients’ medical and psychosocial experiences following detection of a CDH1 variant with multiplex genetic testing.

Jada Hamilton

1583

Frequency of actionable cancer predisposing germline mutations in patients with lung cancers.

Semanti Mukherjee

1504

Genetic testing and results in population-based breast cancer patients and ovarian cancer patients.

Allison W. Kurian

1578

Germline sequencing of advanced prostate cancer patients in the BARCODE2 study.

Sarah Benafif

e13617

Impact of germline BRCA identification on subsequent breast cancer stage and therapy: Implications for routine screening.

Tal Hadar

1584

Impact of pre-surgical germline multigene panel testing on choice of surgery for breast cancer.

Elena Zarcaro

1579

Implementation of strategies to increase genetic counseling referral rates for ovarian cancer patients.

Kara J. Milliron

1590

Implementing genetic risk assessment in a community free clinic.

Leah Marsh

1585

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).

Matthew B. Yurgelun

1512

Incidence of germline BRCA1 and BRCA2 mutations among Filipinos.

Frances Victoria Fajardo Que

e13628

Incidence of pathogenic variants in individuals with a personal or family history of pancreatic cancer.

Pashtoon Murtaza Kasi

1589

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling.

Virginia Speare

e13613

Low utilization of pre-implantation genetic diagnosis in women with BRCA mutations.

Deanna Gerber

e13619

Mismatch Repair Genes and EPCAM germline mutations in patients with gastric or colorectal cancer with suspected of Lynch syndrome.

Nora Manoukian Forones

e13623

Molecular characterization and clinical features of Chinese pulmonary sarcomatoid carcinoma: analysis of 36 cases.

Di Wu

e13616

Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.

Sarah A. Jackson

1580

Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients.

Ava Kwong

e13625

Multiplex germline testing in selected melanomas presenting to oncology clinic.

Pauline Funchain

1588

Pan-cancer microsatellite instability to predict for presence of Lynch syndrome.

Alicia Latham Schwark

LBA1509

Pathogenic germline BRCA1/2 mutations and familial predisposition to gastric cancer.

Hiroshi Ichikawa

e13618

Prevalence of germline genetic alterations in colorectal cancer patients.

Andrea Cercek

1577

Promoting breast cancer screening after multiplex genetic panel testing (MGPT) and genetic counseling.

Gregory Idos

1581

Promoting colorectal cancer (CRC) screening after multiplex genetic testing and genetic counseling.

Gregory Idos

1582

Referral patterns and attrition rate for germline testing in pancreatic cancer (PC) patients.

Evan Justin Walker

1591

The impact of genetic counseling on patients' knowledge about tumor genomic profiling.

Rebecca D. Pentz

1592

The incidence of germline cancer susceptibility mutations in primary CNS neoplasm patients.

Katharine Lord

1586

Universal genetic screening for Chinese colorectal cancer patients with higher hereditary susceptibility.

Shiyong Li

e13620

Validation of a combined residual risk score for healthy unaffected women presenting to breast cancer (BC) screening centers.

Kathryn Dalton

1507

Value of germline multi-gene panel next generation sequencing (NGS) in identification of hereditary cancer syndromes (HCS) in colorectal cancer population (CRC).

Jing Gu

1587

What factors drive the choice of a genetic test? A prospective study of the preferences of women with ovarian cancer.

Brittany Anne Davidson

e13621

Whole BRCA1/2 exome screening in breast cancer tissue: Preliminary study on 45 patients negative in preventive screening analysis in Poland which cover the most common mutations in BRCA1/2 tested in blood.

Marzena Anna Lewandowska

e13615